Rutgers Cancer Institute of New Jersey: First New Jersey Patient Treated With Genetically Modified T-Cells Developed at State's Only National Cancer Institute-Designated Comprehensive Cancer Center
July 06, 2023
July 06, 2023
NEW BRUNSWICK, New Jersey, July 6 (TNSres) -- Rutgers Cancer Institute of New Jersey issued the following news:
Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center together with RWJBarnabas Health, has treated its first patient using genetically modified T-cells that were manufactured in its own state-of-the-art Good Manufacturing Practices (GMP) facility, a fully commissioned clean space for manufacturing of vira . . .
Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center together with RWJBarnabas Health, has treated its first patient using genetically modified T-cells that were manufactured in its own state-of-the-art Good Manufacturing Practices (GMP) facility, a fully commissioned clean space for manufacturing of vira . . .